![Clinical predictors of low CD4 count among HIV-infected pulmonary tuberculosis clients: a health facility-based survey Clinical predictors of low CD4 count among HIV-infected pulmonary tuberculosis clients: a health facility-based survey](http://www.scielo.org.za/img/revistas/samj/v100n9/a24tab02.gif)
Clinical predictors of low CD4 count among HIV-infected pulmonary tuberculosis clients: a health facility-based survey
![Nutrients | Free Full-Text | The Body Fat Percentage Rather Than the BMI Is Associated with the CD4 Count among HIV Positive Japanese Individuals Nutrients | Free Full-Text | The Body Fat Percentage Rather Than the BMI Is Associated with the CD4 Count among HIV Positive Japanese Individuals](https://pub.mdpi-res.com/nutrients/nutrients-14-00428/article_deploy/html/images/nutrients-14-00428-ag-550.jpg?1642579023)
Nutrients | Free Full-Text | The Body Fat Percentage Rather Than the BMI Is Associated with the CD4 Count among HIV Positive Japanese Individuals
View of CD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature | Annals of Gastroenterology
![Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study - The Lancet Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study - The Lancet](https://www.thelancet.com/cms/attachment/2001011323/2003796795/gr1.jpg)
Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per μL in Europe and North America: a pooled cohort observational study - The Lancet
![CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater CD4 Cell Counts of 800 Cells/mm3 or Greater After 7 Years of Highly Active Antiretroviral Therapy Are Feasible in Most Patients Starting With 350 Cells/mm3 or Greater](https://www.natap.org/2008/images/112108/TableCd-1.gif)